AutekBio raises $1.1M for contract cell lines
August 7, 2007 | David P. Hamilton
Santa Clara, Calif.’s AutekBio, a Silicon Valley-Beijing hybrid that grows engineered cell lines for drug companies, raised $1.1 million. See our story in today’s daily briefing at VentureBeat Life Sciences.
Next Story: DFJ partners with Esprit in Europe, to form DFJ Esprit
Previous Story: Capnia names former Glaxo, Alza chief Ernest Mario as CEO
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VB Writers
East Coast Editor
Dean TakahashiLead Writer, GamesBeat
National Editor, MobileBeat Lead
Executive Editor
Editor-in-Chief, GamesBeat
Senior Editor
Writer
Writer
Founder & Editor-in-Chief
Writer
Editorial Assistant
Writer
Reviews Editor, GamesBeat
Tom CheredarWriter
Contributor
Julia PlevinContributor
Contributor









